As of 2025-12-27, the Intrinsic Value of Biovaxys Technology Corp (BIOV.CN) is -1.36 CAD. This BIOV.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.24 CAD, the upside of Biovaxys Technology Corp is -668.59%.
Based on its market price of 0.24 CAD and our intrinsic valuation, Biovaxys Technology Corp (BIOV.CN) is overvalued by 668.59%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.36 - -1.36 | -1.36 | -668.59% |
| P/E | (0.01) - (0.02) | (0.01) | -105.3% |
| DDM - Stable | (3.64) - 589.45 | 292.91 | 121944.0% |
| DDM - Multi | (2.36) - 301.50 | (4.79) | -2096.4% |
| Market Cap (mil) | 5.74 |
| Beta | 0.76 |
| Outstanding shares (mil) | 23.91 |
| Enterprise Value (mil) | 5.87 |
| Market risk premium | 5.10% |
| Cost of Equity | 6.41% |
| Cost of Debt | 5.00% |
| WACC | 6.38% |